Long-term antibody persistence after a booster dose of quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine in healthy 5-year-old children
- 7 May 2020
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 38 (22), 3902-3908
- https://doi.org/10.1016/j.vaccine.2020.02.030
Abstract
No abstract availableFunding Information
- Pfizer Inc
This publication has 19 references indexed in Scilit:
- Recent changes in the epidemiology of Neisseria meningitidis serogroup W across the world, current vaccination policy choices and possible future strategiesHuman Vaccines & Immunotherapeutics, 2018
- Immunogenicity, Safety and Antibody Persistence of a Booster Dose of Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine Compared with Monovalent Meningococcal Serogroup C Vaccine Administered Four Years After Primary Vaccination Using the Same VaccinesThe Pediatric Infectious Disease Journal, 2015
- Antibody persistence to meningococcal serogroups A, C, W and Y in toddlers two years after vaccination with a quadrivalent meningococcal ACWY-tetanus toxoid conjugate (MenACWY-TT) vaccine as measured by bactericidal antibody assays using rabbit or human complementTrials in Vaccinology, 2014
- One or Two Doses of Quadrivalent Meningococcal Serogroups A, C, W-135 and Y Tetanus Toxoid Conjugate Vaccine Is Immunogenic in 9- to 12-Month-Old ChildrenThe Pediatric Infectious Disease Journal, 2013
- Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlersHuman Vaccines & Immunotherapeutics, 2012
- Importance of circulating antibodies in protection against meningococcal diseaseHuman Vaccines & Immunotherapeutics, 2012
- Meningococcal disease: Clinical presentation and sequelaeVaccine, 2012
- Tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine is well tolerated and immunogenic when co-administered with measles–mumps–rubella–varicella vaccine during the second year of life: An open, randomized controlled trialVaccine, 2011
- Validation of Serological Correlate of Protection for Meningococcal C Conjugate Vaccine by Using Efficacy Estimates from Postlicensure Surveillance in EnglandClinical and Vaccine Immunology, 2003
- HUMAN IMMUNITY TO THE MENINGOCOCCUSThe Journal of Experimental Medicine, 1969